Kristoffer Sahlholm

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: ACS CHEMICAL NEUROSCIENCE. 2025;16(13):2502-2512
Estimation of Dopamine D₁ Receptor Agonist Binding Kinetics Using Time-Resolved Functional Assays: Relation to Agonist-Induced Receptor Internalization by Investigational Antiparkinsonian Therapeutics
Sahlholm K; Svensson P; Malo M; Andersson DR; Betari N
Journal article: BIOCHEMISTRY AND BIOPHYSICS REPORTS. 2025;42:102019
A nanoluciferase complementation-based assay for monitoring β-arrestin2 recruitment to the dopamine D3 receptor
Burstrom V; Xu K; Garro-Martinez E; Mach RH; Sahlholm K; Betari N
Article: NEUROTHERAPEUTICS. 2024;21(2):e00334
Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis
Stan TL; Ronaghi A; Barrientos SA; Halje P; Censoni L; Garro-Martinez E; Nasretdinov A; Malinina E; Hjorth S; Svensson P; Waters S; Sahlholm K; Petersson P
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2023;26(9):599-606
In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics
Agren R; Betari N; Saarinen M; Zeberg H; Svenningsson P; Sahlholm K
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(13):10924
An E280K Missense Variant in KCND3/Kv4.3-Case Report and Functional Characterization
Agren R; Geerdink N; Brunner HG; Paucar M; Kamsteeg E-J; Sahlholm K
Article: MOLECULAR BIOLOGY AND EVOLUTION. 2023;40(6):msad130
Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From Neandertals
Agren R; Patil S; Zhou X; FinnGen; Sahlholm K; Paabo S; Zeberg H
Article: BRITISH JOURNAL OF PHARMACOLOGY. 2023;180(7):958-974
Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects
Lopez-Cano M; Font J; Aso E; Sahlholm K; Cabre G; Giraldo J; De Koninck Y; Hernando J; Llebaria A; Fernandez-Duenas V; Ciruela F
Article: BIOMEDICINE & PHARMACOTHERAPY. 2023;160:114327
Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization
Valle-Leon M; Casajuana-Martin N; del Torrent CL; Argerich J; Gomez-Acero L; Sahlholm K; Ferre S; Pardo L; Ciruela F
Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1087171
Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
Burstrom V; agren R; Betari N; Valle-Leon M; Garro-Martinez E; Ciruela F; Sahlholm K
Journal article: NEUROSCIENCE APPLIED. 2023;2:103686
Insights of schizophrenia associated dopamine D2 receptor variants: interplay with the adenosinergic system
Ciruela F; Valle-León M; del Torrent CL; Álvarez-Montoya P; López-Cano M; Casajuana-Martin N; Ferré S; Pardo L; Sahlholm K
Article: NEUROPSYCHOPHARMACOLOGY. 2022;47(13):2319-2329
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT_1A receptor agonist SEP-383856
Saarinen M; Mantas I; Flais I; Agren R; Sahlholm K; Millan MJ; Svenningsson P
Article: BIOMEDICINES. 2021;10(1):22
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D₂ Receptor
agren R; Sahlholm K
Article: FASEB JOURNAL. 2021;35(11):e22013
G protein-coupled receptor kinase-2 confers isoform-specific calcium sensitivity to dopamine D₂ receptor desensitization
Agren R; Sahlholm K
Article: FUTURE MEDICINAL CHEMISTRY. 2021;13(17):1465-1474
Synthetic corticosteroids as tryptophan hydroxylase stabilizers
Betari N; Teigen K; Sahlholm K; Haavik J
Article: CHEMICAL SCIENCE. 2021;12(33):10990-11003
Mechanistic insights into dopaminergic and serotonergic neurotransmission - concerted interactions with helices 5 and 6 drive the functional outcome
Stepniewski TM; Mancini A; Agren R; Torrens-Fontanals M; Semache M; Bouvier M; Sahlholm K; Breton B; Selent J
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(8):4078
Dopamine D₂ Receptor Agonist Binding Kinetics-Role of a Conserved Serine Residue
Agren R; Stepniewski TM; Zeberg H; Selent J; Sahlholm K
Article: BIOMOLECULES. 2021;11(4):529
Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods
Hsieh C-J; Riad A; Lee JY; Sahlholm K; Xu K; Luedtke RR; Mach RH
Article: NEUROLOGY-GENETICS. 2021;7(1):e546
V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations
Paucar M; Agren R; Li T; Lissmats S; Bergendal A; Weinberg J; Nilsson D; Savichetva I; Sahlholm K; Nilsson J; Svenningsson P
Article: NEUROPSYCHOPHARMACOLOGY. 2021;46(3):665-672
Decreased striatal adenosine A_2A-dopamine D₂receptor heteromerization in schizophrenia
Valle-Leon M; Callado LF; Aso E; Cajiao-Manrique MM; Sahlholm K; Lopez-Cano M; Soler C; Altafaj X; Watanabe M; Ferre S; Fernandez-Duenas V; Menchon JM; Ciruela F
Article: FRONTIERS IN PHARMACOLOGY. 2020;11:593416
Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole-In Vitro and In Vivo Investigations
Betari N; Sahlholm K; Morato X; Godoy-Marin H; Jauregui O; Teigen K; Ciruela F; Haavik J
Article: FRONTIERS IN PHARMACOLOGY. 2020;11:581151
Voltage-Dependent Dopamine Potency at D₁-Like Dopamine Receptors
Agren R; Sahlholm K
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(19):3130-3143
Ligand with Two Modes of Interaction with the Dopamine D₂ Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism
Agren R; Zeberg H; Stepniewski TM; Free RB; Reilly SW; Luedtke RR; Arhem P; Ciruela F; Sibley DR; Mach RH; Selent J; Nilsson J; Sahlholm K
Article: CURRENT BIOLOGY. 2020;30(17):3465-3469.e4
A Neanderthal Sodium Channel Increases Pain Sensitivity in Present-Day Humans
Zeberg H; Dannemann M; Sahlholm K; Tsuo K; Maricic T; Wiebe V; Hevers W; Robinson HPC; Kelso J; Paeaebo S
Article: FUTURE MEDICINAL CHEMISTRY. 2020;12(16):1461-1474
Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis
Betari N; Sahlholm K; Ishizuka Y; Teigen K; Haavik J
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2019;62(10):5132-5147
Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D₃ Receptor (D₃R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)
Reilly SW; Riad AA; Hsieh C-J; Sahlholm K; Jacome DA; Griffin S; Taylor M; Weng C-C; Xu K; Kirschner N; Luedtke RR; Parry C; Malhotra S; Karanicolas J; Mach RH
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2018;21(12):1102-1108
The Beta-Arrestin-Biased Dopamine D₂ Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation
Agren R; Arhem P; Nilsson J; Sahlholm K
Journal article: 2018
Pridopidine reverses phencyclidine-induced memory impairment
Sahlholm K
Article: CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2018;17(7):522-527
Effects of the Dopamine Stabilizer, Pridopidine, on Basal and Phencyclidine-Induced Locomotion: Role of Dopamine D₂ and Sigma-1 Receptors
Sahlholm K; Valle-Leon M; Taura J; Fernandez-Duenas V; Ciruela F
Article: MOLECULAR NEUROBIOLOGY. 2018;55(6):4952-4958
Antipsychotic-Like Efficacy of Dopamine D₂ Receptor-Biased Ligands is Dependent on Adenosine A_2A Receptor Expression
Sahlholm K; Gomez-Soler M; Valle-Leon M; Lopez-Cano M; Taura JJ; Ciruela F; Fernandez-Duenas V
Article: FRONTIERS IN PHARMACOLOGY. 2018;9:338
Pridopidine Reverses Phencyclidine-Induced Memory Impairment
Sahlholm K; Valle-Leon M; Fernandez-Duenas V; Ciruela F
Article: GENES BRAIN AND BEHAVIOR. 2018;17(4):e12432
Behavioral control by striatal adenosine A_2A-dopamine D₂ receptor heteromers
Taura J; Valle-Leon M; Sahlholm K; Watanabe M; Van Craenenbroeck K; Fernandez-Duenas V; Ferre S; Ciruela F
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2018;496(1):101-104
Point mutation of a conserved aspartate, D69, in the muscarinic M₂ receptor does not modify voltage-sensitive agonist potency
Agren R; Sahlholm K; Nilsson J; Arhem P
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2017;60(23):9905-9910
Highly Selective Dopamine D₃ Receptor Antagonists with Arylated Diazaspiro Alkane Cores
Reilly SW; Griffin S; Taylor M; Sahlholm K; Weng C-C; Xu K; Jacome DA; Luedtke RR; Mach RH
Article: PSYCHOPHARMACOLOGY. 2017;234(13):2019-2030
The role of beta-arrestin2 in shaping fMRI BOLD responses to dopaminergic stimulation
Sahlholm K; Ielacqua GD; Xu J; Jones LA; Schlegel F; Mach RH; Rudin M; Schroeter A
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26(3):467-476
The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D₂ receptor
Sahlholm K; Zeberg H; Nilsson J; Ogren SO; Fuxe K; Arhem P
Article: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2015;137(50):15892-15898
Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells
Soto-Cerrato V; Manuel-Manresa P; Hernando E; Calabuig-Farinas S; Martinez-Romero A; Fernandez-Duenas V; Sahlholm K; Knoepfel T; Garcia-Valverde M; Rodilla AM; Jantus-Lewintre E; Farras R; Ciruela F; Perez-Tomas R; Quesada R
Article: PSYCHOPHARMACOLOGY. 2015;232(18):3443-3453
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
Sahlholm K; Sijbesma JWA; Maas B; Kwizera C; Marcellino D; Ramakrishnan NK; Dierckx RAJO; Elsinga PH; van Waarde A
Article: MOLECULAR PAIN. 2015;11:44
G protein-gated inwardly rectifying potassium channel subunits 1 and 2 are down-regulated in rat dorsal root ganglion neurons and spinal cord after peripheral axotomy
Lyu C; Mulder J; Barde S; Sahlholm K; Zeberg H; Nilsson J; Arhem P; Hokfelt T; Fried K; Shi T-JS
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2015;460(2):439-445
Sigma-2 receptor binding is decreased in female, but not male, APP/PS1 mice
Sahlholm K; Liao F; Holtzman DM; Xu J; Mach RH
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2014;17(1):149-155
Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D₂ receptor
Sahlholm K; Marcellino D; Nilsson J; Ogren SO; Fuxe K; Arhem P
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2012;1818(12):3081-3089
Voltage sensitivities and deactivation kinetics of histamine H₃ and H₄ receptors
Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2012;22:s29
P.1.030 Antagonist dissociation from dopamine D2 receptors: studies using a time-resolved ion channel activation assay
Sahlholm K; Frisk S; Marcellino D; Nilsson J; Fuxe K; Århem P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;415(3):509-514
The role of RGS protein in agonist-dependent relaxation of GIRK currents in Xenopus oocytes
Sahlholm K
Article: NEUROPHARMACOLOGY. 2011;61(5-6):937-949
Agonist-specific voltage sensitivity at the dopamine D_2S receptor - Molecular determinants and relevance to therapeutic ligands
Sahlholm K; Barchad-Avitzur O; Marcellino D; Gomez-Soler M; Fuxe K; Ciruela F; Arhem P
Article: EUROPEAN JOURNAL OF NEUROSCIENCE. 2010;32(8):1265-1277
Evidence for oligomerization between GABA_B receptors and GIRK channels containing the GIRK1 and GIRK3 subunits
Ciruela F; Fernandez-Duenas V; Sahlholm K; Fernandez-Alacid L; Nicolau JC; Watanabe M; Lujan R
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010;394(4):988-992
Cocaine produces D₂R-mediated conformational changes in the adenosine A_2AR-dopamine D₂R heteromer
Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluis C; Arhem P; Franco R; Fuxe K
Journal article: BIOPHYSICAL JOURNAL. 2009;96(3):561a-562a
Role of Aromatic Residues for Local Anaesthetic Binding to Ion Channels
Johanna N; Ullman H; Sahlholm K; Arhem P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2008;377(4):1216-1221
Voltage-sensitivity at the human dopamine D_2S receptor is agonist-specific
Sahlholm K; Marcellino D; Nilsson J; Fuxe K; Arhem P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2008;374(3):496-501
Differential voltage-sensitivity of D₂-like dopamine receptors
Sahlholm K; Marcellino D; Nilsson J; Fuxe K; Arhem P
Article: EUROPEAN JOURNAL OF PHARMACOLOGY. 2008;591(1-3):52-58
Electrophysiology-based analysis of human histamine H₄ receptor pharmacology using GIRK channel coupling in Xenopus oocytes
Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
Article: SYNAPSE-STRUCTURE FUNCTION CONNECTIVITY. 2008;62(6):476-480
Voltage-dependence of the human dopamine D₂ receptor
Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
Article: EUROPEAN JOURNAL OF PHARMACOLOGY. 2007;567(3):206-210
The human histamine H₃ receptor couples to GIRK channels in Xenopus oocytes
Sahlhollm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
Article: BMC NEUROSCIENCE. 2005;6:65
A truncated Kv1.1 protein in the brain of the megencephaly mouse:: expression and interaction -: art. no. 65
Persson AS; Klement G; Almgren M; Sahlholm K; Nilsson J; Petersson S; Århem P; Schalling M; Lavebratt C
Visa fler

Alla övriga publikationer

Conference publication: NEUROPSYCHOPHARMACOLOGY. 2023;48:391
Pharmacological Characterization of Potent Human Trace Amine-Associated Receptor 1 (TAAR1) Agonists
Saarinen M; Diaz A; Agren R; Betari N; Zeberg H; Sahlholm K; Carlsson J; Svenningsson P
Corrigendum: NEUROPSYCHOPHARMACOLOGY. 2023;48(5):846
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT_1A receptor agonist SEP- 363856 (vol 47, pg 2319, 2022)
Saarinen M; Mantas I; Flais I; Agren R; Sahlholm K; Millan MJ; Svenningsson P
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2022;47:391
TAAR1 Dependent and Independent Actions of the Potential Antipsychotic and Dual TAAR1/5HT1A Receptor Agonist SEP-383856
Svenningson P; Saarinen M; Mantas I; Flais I; Agren R; Sahlholm K; Millan MJ
Corrigendum: NEUROLOGY-GENETICS. 2021;7(2):e567
V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations (vol 7, e546, 2021)
Paucar M; Agren R; Li T; Lissmats S; Bergendal A; Weinberg J; Nilsson D; Savichetva I; Sahlholm K; Nilsson J; Svenningsson P
Conference publication: MOVEMENT DISORDERS. 2020;35:S21-S22
Novel KCND3 mutation associated with paroxysmal motor exacerbations in spinocerebellar ataxia 19
Paucar M; Agren R; Li T; Lissmats S; Bergendal A; Savitcheva I; Nilsson D; Sahlholm K; Svenningsson P; Nilsson J
Conference publication: BEHAVIOR GENETICS. 2019;49(6):550
Missense SNPs in dopamine receptors: function, evolution and associations
Zeberg H; Sahlholm K
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S237-s238
Pridopidine reverses phencyclidine-induced memory impairment
Sahlholm K; Valle-Leon M; Fernandez-Duenas V; Ciruela F
Editorial comment: FUTURE MEDICINAL CHEMISTRY. 2018;10(23):2675-2677
Dopamine receptor heteromers: biasing antipsychotics
Sahlholm K; Valle-Leon M; Fernandez-Duenas V; Ciruela F
Letter: NATURE COMMUNICATIONS. 2018;9(1):3577
Antipsychotics with similar association kinetics at dopamine D₂ receptors differ in extrapyramidal side-effects
Zeberg H; Sahlholm K
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2015;42:S20
Sigma-1 and dopamine D2 receptor occupancy of the dopamine stabilizer pridopidine in the brain of living rats
Sahlholm K; Sijbesma JWA; Maas B; Kwizera C; Ramakrishnan NK; Dierckx RAJO; Elsinga PH; Van Waarde A
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S520
The fast-off hypothesis revisited: on-rates and reversibility of antipsychotic antagonism at the D2 receptor
Sahlholm K; Zeberg H; Marcellino D; Nilsson J; Ogren SO; Fuxe K; Arhem P
Conference publication: EPILEPSIA. 2014;55:123-124
ANTIEPILEPTIC DRUG BINDING TO POTASSIUM CHANNELS: ROLE OF AROMATIC RESIDUES
Nilsson J; Sahlholm K; Arhem P
Meeting abstract: BIOPHYSICAL JOURNAL. 2013;104(2):26A
Novel Aspects of the Reversibility of the Antagonism at the Dopamine D2 Receptor by Antipsychotics
Sahlholm K; Frisk S; Nilsson J; Marcellino D; Fuxe K; Ogren SO; Arhem P
Letter: MOLECULAR PSYCHIATRY. 2013;18(1):12-14
The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the σ-1 receptor
Sahlholm K; Arhem P; Fuxe K; Marcellino D
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15:167
Antagonist dissociation from dopamine D2 receptors - dopamine stabilizers unbind faster than clozapine and quetiapine
Sahlholm K; Frisk S; Marcellino D; Nilsson J; Fuxe K; Arhem P
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15:166
The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the o-1 receptor
Marcellino D; Sahlholm K; Arhem P; Fuxe K
Meeting abstract: BIOPHYSICAL JOURNAL. 2012;102(3):517A
Dopamine D2 Receptor Antagonist Unbinding Rates Investigated using a Time-Resolved Ion Channel Activation Assay
Sahlholm K; Frisk S; Nilsson J; Marcellino D; Fuxe K; Arhem P
Doctoral thesis: 2011
Voltage sensitivity of dopamine D2-like receptors
Sahlholm K
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2011;21:S511-S512
Investigation of antagonist unbinding from dopamine D₂ receptors using a real-time ion channel activation assay
Sahlholm K; Frisk S; Fuxe K; Arhem P
Meeting abstract: BIOPHYSICAL JOURNAL. 2010;98(3):290A
Agonist-Specific Effects of TM V Serine Mutations on Dopamine D2S Receptor Voltage-Sensitivity
Sahlholm K; Marcellino D; Nilsson J; Fuxe K; Arhem P
Meeting abstract: BIOPHYSICAL JOURNAL. 2010;98(3):213A
Kv Channel Modulation: Closed State Block of Benzocaine But Not of Bupivacaine
Nilsson J; Madeja M; Sahlholm K; Arhem P
Meeting abstract: BIOPHYSICAL JOURNAL. 2009;96(3):369A
Differential Voltage-sensitivities Of Agonists At The Dopamine D_2S Receptor
Sahlholm K; Marcellino D; Nilsson J; Fuxe K; Arhem P
Conference publication: BIOPHYSICAL JOURNAL. 2007;:17A
Cocaine effects on D₂-receptor activation and coupling to GIRKs
Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
Book chapter: ANAESTHESIA SCIENCE. 2006;p. 117-127
Mechanisms of Anaesthesia: A Role for Voltage‐Gated K Channels?
Århem P; Sahlholm K; Nilsson J
Conference publication: BIOPHYSICAL JOURNAL. 2005;88(1):282A
Kv1.1 truncation induced megencephaly - Regulation of Kv1 expression
Klement G; Persson AS; Nilsson J; Sahlholm K; Lavebratt-Holmquist C; Arhem P
Visa fler

Anställningar

Anknuten till Forskning, Fysiologi och farmakologi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för neurovetenskap, Karolinska Institutet, 2011
Medicine Magisterexamen, Karolinska Institutet, 2010

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI